Mental Health Clinical Trials in the UK (2026): Depression, Anxiety, PTSD and Beyond
Mental health clinical trials in the UK are entering a golden age. From psychedelic-assisted therapy to AI-driven digital treatments and precision psychiatry, researchers are exploring entirely new ways to treat conditions that affect one in four people each year. This guide covers what is available and how to get involved.
The New Era of Mental Health Research
For decades, mental health treatment relied on a relatively small pool of medications and talking therapies. That is changing rapidly. Clinical trials in the UK are now testing psychedelic compounds like psilocybin for depression and MDMA for PTSD — approaches that were unthinkable a decade ago. Digital therapeutics, including app-based cognitive behavioural therapy and virtual reality exposure therapy, are being validated in rigorous trials. Precision psychiatry aims to match patients to treatments based on genetic markers, brain imaging, and digital phenotyping.
Depression and Anxiety Trials
Depression and anxiety remain the most common mental health conditions in clinical trials. Treatment-resistant depression (TRD) — where patients have not responded to two or more antidepressants — is a particular focus. Trials are testing ketamine and esketamine (Spravato), psilocybin, transcranial magnetic stimulation (TMS), and novel glutamate modulators. For anxiety, trials are exploring new selective treatments that reduce anxiety without the sedation and dependency risks of traditional benzodiazepines.
PTSD and Trauma-Focused Trials
PTSD research has accelerated dramatically, driven partly by increased awareness among military veterans, healthcare workers, and trauma survivors. MDMA-assisted therapy trials have shown remarkable results internationally, and UK centres are now participating in larger studies. Other PTSD trials are testing eye movement desensitisation and reprocessing (EMDR) enhancements, virtual reality exposure therapy, and novel pharmacological approaches targeting the fear extinction pathway.
How to Access Mental Health Trials Through the NHS
Most mental health trials in the UK run through NHS mental health trusts, IAPT (Improving Access to Psychological Therapies) services, and specialist psychiatric centres. You can be referred by your GP, psychiatrist, or community mental health team. Some trials accept self-referral. The NIHR Mental Health Translational Research Collaboration coordinates trials across the country, ensuring wide geographic access. Your care team will not be replaced — they remain involved throughout your participation.